Articles in section Mergers & Acquisitions

<< Licensing

725 articles

Opinion & Analysis >>

Pages 1 2 3 4 5 .. 73

Next >>

Merck KGaA Acquires Bio-Techne for up to US$11.3 B Published: 28 Aug-2026
By: Nikita Negi
Abstract Fulltext:
Volume: 2026 Issue: 8
Jazz Pharmaceuticals Expands Rare Epilepsy Portfolio with US$1.32 B Acquisition of Actio Biosciences Published: 17 Aug-2026
By: Sanya Sekhri
Abstract Fulltext:
Volume: 2026 Issue: 8
Tarsus Pharmaceuticals Expands Eye Care Portfolio with Acquisition of Alkeus Pharmaceuticals Published: 14 Aug-2026
By: Nikita Negi
Abstract Fulltext:
Volume: 2026 Issue: 8
Supernus and Indivior Merge to Create a CNS-Focused Drug Company Published: 12 Aug-2026
By: Ayush Saxena
Abstract Fulltext:
Volume: 2026 Issue: 8
Argenx to Acquire Forte Biosciences for US$2.2 B Published: 1 Aug-2026
By: Ayush Saxena
Abstract Fulltext:
Volume: 2026 Issue: 8
Novartis Expands Oncology Portfolio with US$1.5 B Acquisition of Myricx Published: 1 Aug-2026
By: Sanya Sekhri
Abstract Fulltext:
Volume: 2026 Issue: 8
Lilly to Acquire AtaiBeckley to Advance Therapies Targeting Resistant Depression and Other Mental Health Conditions for US$3.8 B Published: 29 Jul-2026
By: Naini Anand
Abstract Fulltext:
Volume: 2026 Issue: 7
Vertex to Acquire Crinetics Pharmaceuticals for US$10 B Published: 25 Jul-2026
By: Ayush Saxena
Abstract Fulltext:
Volume: 2026 Issue: 7
Ipsen Expands Rare Disease Portfolio with US$1 B+ Acquisition of Memo Therapeutics Published: 16 Jul-2026
By: Naini Anand
Abstract Fulltext:
Volume: 2026 Issue: 7
AbbVie Deepens Immunology Leadership with US$10.9 B Acquisition of Apogee Therapeutics Published: 16 Jul-2026
By: Nikita Negi
Abstract Fulltext:
Volume: 2026 Issue: 7

PharmaDeals will be moved to a new platform by October 31, 2026. Please look out for an email from your IQVIA account manager by the end of September with details.

Login

Username:

Password:

Keep me logged in